Detailed Information on Publication Record
2018
C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies
STAŇO KOZUBÍK, Kateřina, Lenka RADOVÁ, Michaela PEŠOVÁ, Kamila RÉBLOVÁ, Jakub TRIZULJAK et. al.Basic information
Original name
C-terminal RUNX1 mutation in familial platelet disorder with predisposition to myeloid malignancies
Authors
STAŇO KOZUBÍK, Kateřina (203 Czech Republic, belonging to the institution), Lenka RADOVÁ (203 Czech Republic, belonging to the institution), Michaela PEŠOVÁ (203 Czech Republic, belonging to the institution), Kamila RÉBLOVÁ (203 Czech Republic, belonging to the institution), Jakub TRIZULJAK (703 Slovakia, belonging to the institution), Karla PLEVOVÁ (203 Czech Republic, belonging to the institution), Veronika FIAMOLI (203 Czech Republic, belonging to the institution), J. GUMULEC (203 Czech Republic), H. URBANKOVA (203 Czech Republic), T. SZOTKOWSKI (203 Czech Republic), Jiří MAYER (203 Czech Republic, belonging to the institution), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution) and Michael DOUBEK (203 Czech Republic, guarantor, belonging to the institution)
Edition
International journal of hematology, Tokyo, Springer Japan KK, 2018, 0925-5710
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30205 Hematology
Country of publisher
Japan
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 2.251
RIV identification code
RIV/00216224:14740/18:00106950
Organization unit
Central European Institute of Technology
UT WoS
000449944200014
Keywords in English
Familial platelet disorder with predisposition to myeloid malignancies; Inherited thrombocytopenia; RUNX1
Tags
International impact, Reviewed
Změněno: 13/3/2019 13:09, Mgr. Pavla Foltynová, Ph.D.
Abstract
V originále
Here we report a C-terminal RUNX1 mutation in a family with platelet disorder and predisposition to myeloid malignancies. We identified the mutation c.866delG:p.Gly289Aspfs*22 (NM_001754) (RUNX1 b-isoform NM_001001890; c.785delG:p.Gly262Aspfs*22) using exome sequencing of samples obtained from eight members of a single family. The mutation found in our pedigree is within exon eight and the transactivation domain of RUNX1. One of the affected individuals developed myelodysplastic syndrome (MDS), which progressed to acute myelogenous leukemia (AML). A search for the second hit which led to the development of MDS and later AML in this individual revealed the PHF6 gene variant (exon9:c.872G>A:p.G291E; NM_001015877), BCORL1 (exon3:c.1111A>C:p.T371P; NM_001184772) and BCOR gene variant (exon4:c.2076dupT:p.P693fs; NM_001123383), which appear to be very likely second hits participating in the progression to myeloid malignancy.
Links
NV16-29447A, research and development project |
|